What are Recombinant protein subunit vaccine drugs?

Recombinant protein subunit vaccine drugs are pharmacologic agents that share a common mechanism (typically targeting Respiratory syncytial virus (RSV) fusion (F) glycoprotein). 1 are currently marketed, with 7 more in clinical development.

What are the marketed Recombinant protein subunit vaccine drugs?

Marketed Recombinant protein subunit vaccine drugs include RSV Vaccine.

Recombinant protein subunit vaccine

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

1 marketed 7 in Phase 3

This page covers all Recombinant protein subunit vaccine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Respiratory syncytial virus (RSV) fusion (F) glycoprotein, SARS-CoV-2 spike protein, HPV L1 capsid protein (types 16 and 18).

Targets

Respiratory syncytial virus (RSV) fusion (F) glycoprotein · SARS-CoV-2 spike protein · HPV L1 capsid protein (types 16 and 18) · SARS-CoV-2 spike protein (S protein) · Plasmodium falciparum circumsporozoite protein (CSP)

Marketed (1)

RSV Vaccine · Pfizer · Immunology / Infectious Disease
This vaccine stimulates the immune system to produce antibodies and cellular immunity against respiratory syncytial virus (RSV) proteins, preventing or reducing severity of RSV infection.

Phase 3 pipeline (7)

NVX-CoV2515 · Novavax · Immunology / Infectious Disease
NVX-CoV2515 is a recombinant protein subunit vaccine that presents the SARS-CoV-2 spike protein to stimulate immune responses against COVID-19 variants.
NVX-CoV2705 Vaccine · Novavax · Immunology / Infectious Disease
NVX-CoV2705 is a recombinant protein subunit vaccine that presents SARS-CoV-2 spike protein antigens to stimulate adaptive immune responses against COVID-19 variants.
Cervavac as two dose regimen · Serum Institute of India Pvt. Ltd. · Oncology / Immunology
Cervavac is a two-dose recombinant protein subunit vaccine that stimulates immune responses against human papillomavirus (HPV) types 16 and 18 to prevent cervical cancer and related precancerous lesions.
EuCorVac-19 · EuBiologics Co.,Ltd · Immunology / Infectious Disease
EuCorVac-19 is a recombinant protein subunit vaccine that stimulates immune responses against SARS-CoV-2 by presenting viral spike protein antigens.
R21/Matrix-M™ · University of Oxford · Infectious Disease / Immunology
R21/Matrix-M is a recombinant protein subunit malaria vaccine that elicits immune responses against the Plasmodium falciparum parasite.
R21Matrix M · London School of Hygiene and Tropical Medicine · Infectious Disease / Immunology
R21/Matrix M is a recombinant protein subunit malaria vaccine that elicits immune responses against the Plasmodium falciparum parasite.
Envacgen® · Medigen Vaccine Biologics Corp. · Immunology / Infectious Disease
Envacgen is a recombinant protein subunit vaccine designed to stimulate immune responses against specific disease targets through antigen presentation.

Patent intelligence

recombinant protein subunit vaccine patent landscape — aggregated cliff calendar, attackable patents, originator estates